HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 274 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $497,807 | +15.8% | 13,035 | +33.3% | 0.08% | +78.6% |
| Q2 2022 | $430,000 | -3.8% | 9,782 | -6.6% | 0.04% | +35.5% |
| Q4 2020 | $447,000 | -66.1% | 10,471 | -78.7% | 0.03% | -73.0% |
| Q2 2020 | $1,319,000 | +129.8% | 49,216 | +52.1% | 0.12% | +45.6% |
| Q4 2019 | $574,000 | – | 32,348 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,506,473 | $61,283,000 | 5.13% |
| First Light Asset Management, LLC | 1,477,496 | $60,105,000 | 3.96% |
| SNYDER CAPITAL MANAGEMENT L P | 3,427,476 | $139,430,000 | 3.69% |
| DOHENY ASSET MANAGEMENT /CA | 80,400 | $3,271,000 | 2.34% |
| Redwood Investments, LLC | 619,766 | $25,212,000 | 2.11% |
| HighMark Wealth Management LLC | 53,341 | $2,170,000 | 1.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 60,170 | $2,448,000 | 1.38% |
| Third Security, LLC | 168,604 | $6,859,000 | 1.33% |
| Taylor Wealth Management Partners | 87,654 | $3,566,000 | 1.27% |
| Penn Capital Management Company, LLC | 290,394 | $11,813,000 | 1.19% |